STOCK TITAN
  1. Home
  2. Sec-filings
  3. FEMY
  4. [8-K] Femasys Inc. Reports Material Event

[8-K] Femasys Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock FEMY logo
FEMASYS INC

NASDAQ:FEMY

FEMY Rankings

#8019 Ranked by Market Cap
N/A Ranked by Dividends

FEMY Latest News

Jul 1, 2025
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic
Jun 25, 2025
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
Jun 17, 2025
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth
Jun 11, 2025
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
May 30, 2025
Femasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 Million

FEMY Latest SEC Filings

Jul 3, 2025
[8-K] Femasys Inc. Reports Material Event
Jul 3, 2025
[S-3] Femasys Inc. Shelf Registration Statement
Jul 1, 2025
[Form 4] Femasys Inc. Insider Trading Activity
Jul 1, 2025
[Form 3] Femasys Inc. Initial Statement of Beneficial Ownership
Jul 1, 2025
[8-K] Femasys Inc. Reports Material Event

FEMY Stock Data

30.86M
29.10M
14.49%
16.46%
2.88%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SUWANEE